Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB26FNMMU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,574
Award facts
- Contract value 100% obligated
- $17,574.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,574.41 to DMS Pharmaceutical Group Inc. on October 15, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at approximately $500 million through November 2026. The delivery is scheduled for completion by November 5, 2025, and will be fulfilled from the contractor's facility in Park Ridge, Illinois. No set-aside designation was used for this procurement.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in 2001, serves as a critical supplier within the federal pharmaceutical supply chain for the Department of Defense. The company specializes in distributing branded and generic prescription medications, biologics, and medical consumables to military and federal healthcare facilities nationwide. EXPAREL, a local anesthetic, represents one of numerous specialty pharmaceutical products the contractor routinely supplies through its DLA contract portfolio, which encompasses oncology treatments, vaccines, auto-injectors, and other specialized medications essential to military health operations globally.
Quick answers
Who was awarded contract SPE2DB26FNMMU?
SPE2DB26FNMMU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FNMMU worth?
The government has obligated $17,574 on SPE2DB26FNMMU.
Is contract SPE2DB26FNMMU an order under another contract?
Yes. SPE2DB26FNMMU is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB26FNMMU competed?
The extent of competition for SPE2DB26FNMMU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award